Position in AMGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$12,743,002
+$361,401 QoQ
Shares Held
35,190
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#473
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 28%
Shared 0%
None 72%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026American Assets Investment Management, LLC holds $105,562,734 across 11 Drug Manufacturers - General names. AMGN ranks #6 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
125,000 | $16,062,500 | |
| 2 | ABBV |
AbbVie Inc.
|
60,294 | $15,172,382 | |
| 3 | NVS |
Novartis AG
|
93,610 | $14,670,559 | |
| 4 | JNJ |
Johnson & Johnson
|
57,000 | $14,476,290 | |
| 5 | LLY |
ELI LILLY & Co
|
12,000 | $14,393,161 | |
| 6 | AMGN |
Amgen Inc
This page
|
35,190 | $12,743,002 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
127,000 | $7,317,740 | |
| 8 | SNY |
Sanofi
|
80,000 | $3,412,800 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,743,002 | 35,190 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $12,381,601 | 35,190 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $11,518,038 | 35,190 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $9,930,618 | 35,190 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $9,825,399 | 35,190 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $10,963,444 | 35,190 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $9,171,921 | 35,190 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $11,338,569 | 35,190 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $10,995,115 | 35,190 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $10,005,220 | 35,190 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $10,135,423 | 35,190 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $9,457,664 | 35,190 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,812,883 | 35,190 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $8,507,182 | 35,190 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $9,242,301 | 35,190 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $7,931,826 | 35,190 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $8,561,727 | 35,190 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $8,509,645 | 35,190 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $7,916,694 | 35,190 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $4,293,403 | 20,190 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $4,921,312 | 20,190 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $5,023,473 | 20,190 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $2,342,884 | 10,190 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,589,890 | 10,190 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $2,403,413 | 10,190 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $2,065,818 | 10,190 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||